Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$1.83+0.01 (+0.55%)
Close on Nov 18, 2026Market cap $568.82MP/E –Yield 0.00%
Pacific Biosciences of California cash
Cash and short-term investments held at the end of each period.
Pacific Biosciences of California's cash was $236.87M at Jun 30, 2026. For fiscal 2025 it was $279.51M, down 28.7% from the year before. Over ten years it grew 12.4% a year on average. The highest annual figure on record is $1.05B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $279.51M | -28.7% |
| FY2024 | Dec 31, 2024 | $392.15M | -37.9% |
| FY2023 | Dec 31, 2023 | $631.42M | -18.6% |
| FY2022 | Dec 31, 2022 | $775.54M | -26.1% |
| FY2021 | Dec 31, 2021 | $1.05B | +224.8% |
| FY2020 | Dec 31, 2020 | $323.15M | +505.2% |
| FY2019 | Dec 31, 2019 | $53.40M | -47.9% |
| FY2018 | Dec 31, 2018 | $102.40M | +62.8% |
| FY2017 | Dec 31, 2017 | $62.90M | -12.6% |
| FY2016 | Dec 31, 2016 | $72.00M | -17.0% |
| FY2015 | Dec 31, 2015 | $86.77M | -14.4% |
| FY2014 | Dec 31, 2014 | $101.35M | -9.9% |
| FY2013 | Dec 31, 2013 | $112.53M | +11.9% |
| FY2012 | Dec 31, 2012 | $100.58M | -43.3% |
| FY2011 | Dec 31, 2011 | $177.43M | -37.5% |
| FY2010 | Dec 31, 2010 | $283.67M | +217.9% |
| FY2009 | Dec 31, 2009 | $89.23M | +13.7% |
| FY2008 | Dec 31, 2008 | $78.46M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $236.87M | -24.7% |
| Q1 FY2026 | Mar 31, 2026 | $275.96M | -19.6% |
| Q4 FY2025 | Dec 31, 2025 | $279.51M | -28.7% |
| Q3 FY2025 | Sep 30, 2025 | $298.65M | -36.6% |
| Q2 FY2025 | Jun 30, 2025 | $314.74M | -38.3% |
| Q1 FY2025 | Mar 31, 2025 | $343.11M | -38.9% |
| Q4 FY2024 | Dec 31, 2024 | $392.15M | -37.9% |
| Q3 FY2024 | Sep 30, 2024 | $471.15M | -38.6% |
| Q2 FY2024 | Jun 30, 2024 | $509.80M | -38.6% |
| Q1 FY2024 | Mar 31, 2024 | $561.91M | -35.8% |
| Q4 FY2023 | Dec 31, 2023 | $631.42M | -18.6% |
| Q3 FY2023 | Sep 30, 2023 | $767.79M | -8.0% |
| Q2 FY2023 | Jun 30, 2023 | $829.86M | -7.7% |
| Q1 FY2023 | Mar 31, 2023 | $874.89M | -9.1% |
| Q4 FY2022 | Dec 31, 2022 | $775.54M | -26.1% |
| Q3 FY2022 | Sep 30, 2022 | $834.34M | -22.7% |
| Q2 FY2022 | Jun 30, 2022 | $899.15M | -21.4% |
| Q1 FY2022 | Mar 31, 2022 | $962.78M | -17.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.05B | +224.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.08B | +417.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.14B | +853.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.16B | +713.7% |
| Q4 FY2020 | Dec 31, 2020 | $323.15M | +505.2% |
| Q3 FY2020 | Sep 30, 2020 | $208.55M | +323.8% |
| Q2 FY2020 | Jun 30, 2020 | $119.96M | +79.5% |
| Q1 FY2020 | Mar 31, 2020 | $142.59M | +72.0% |
| Q4 FY2019 | Dec 31, 2019 | $53.40M | -47.9% |
| Q3 FY2019 | Sep 30, 2019 | $49.20M | -57.5% |
| Q2 FY2019 | Jun 30, 2019 | $66.84M | +5.3% |
| Q1 FY2019 | Mar 31, 2019 | $82.90M | +4.6% |
| Q4 FY2018 | Dec 31, 2018 | $102.40M | +62.8% |
| Q3 FY2018 | Sep 30, 2018 | $115.75M | +37.8% |
| Q2 FY2018 | Jun 30, 2018 | $63.49M | -38.1% |
| Q1 FY2018 | Mar 31, 2018 | $79.26M | +41.4% |
| Q4 FY2017 | Dec 31, 2017 | $62.90M | -12.6% |
| Q3 FY2017 | Sep 30, 2017 | $84.00M | -3.8% |
| Q2 FY2017 | Jun 30, 2017 | $102.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $56.05M | – |
| Q4 FY2016 | Dec 31, 2016 | $72.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $87.33M | – |
See a number that looks wrong?